Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SEQUENT SCIENTIFIC Gains 5%; BSE HEALTHCARE Index Up 0.9%
Wed, 6 Nov 10:9

SEQUENT SCIENTIFIC Gains 5%; BSE HEALTHCARE Index Up 0.9%Image source: alexsl/www.istockphoto.com

SEQUENT SCIENTIFIC share price has zoomed 5% and is presently trading at Rs 220.7.

Meanwhile, the BSE HEALTHCARE index is at 44,304.5 (up 0.9%).

Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 2.6%) and Dr. Reddys (up 2.2%).

SUVEN PHARMACEUTICALS (down 0.6%) and Jubilant Pharmova (down 0.6%) are among the top losers today.

Over the last one year, SEQUENT SCIENTIFIC has moved up from Rs 100.7 to Rs 220.7, registering a gain of Rs 120.0 (up 119.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,089.2 to 44,304.5, registering a gain of 57.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 207.8%), SUVEN PHARMACEUTICALS (up 132.2%) and Glenmark Pharma (up 129.9%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,060.2 (up 0.7%).

The top gainers among the BSE Sensex today are HCl Tech. (up 3.1%) and Infosys (up 3.1%). The most traded stocks in the BSE Sensex are ITC and Infosys.

In the meantime, NSE Nifty is at 24,401.2 (up 0.8%). Trent and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,958.7 to 80,060.2, registering a gain of 15,101.5 points (up 23.2%).

SEQUENT SCIENTIFIC Financial Update...

SEQUENT SCIENTIFIC net profit grew 126.1% YoY to Rs 91 million for the quarter ended June 2024, compared to a loss of Rs 347 million a year ago. Net sales rose 17.1% to Rs 3,902 million during the period as against Rs 3,332 million in April-June 2023.

For the year ended March 2024, SEQUENT SCIENTIFIC reported 75.7% increase in net profit to Rs -296 million compared to net loss of Rs 1,220 million during FY23. Revenue of the company fell 3.6% to Rs 13,697 million during FY24.

The current Price to earnings ratio of SEQUENT SCIENTIFIC, based on rolling 12 month earnings, stands at 390.2.


Equitymaster requests your view! Post a comment on "SEQUENT SCIENTIFIC Gains 5%; BSE HEALTHCARE Index Up 0.9%". Click here!